Endo acquires HealthTronics

Download PDF Copy

Jul 15 2010

NewsGuard 100/100 Score

Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of HealthTronics, Inc. (Nasdaq: HTRN), a leading U.S. provider of urological products and services, located in Austin, Texas.

On July 12, 2010, Endo acquired HealthTronics through a tender offer and subsequent merger upon which HealthTronics became a wholly owned subsidiary of Endo.

"The HealthTronics acquisition marks an important step forward in Endo's strategy to diversify beyond pharmaceuticals and solidifies Endo's commitment to the field of Urology," said Dave Holveck, president and CEO of Endo. "Urology practices, the patients they serve and payers will all benefit from the integration of Endo and HealthTronics through our combined expertise, products and services."

SOURCE Endo Pharmaceuticals

Posted in:

Tags: Anti-Inflammatory, Bladder Cancer, Cancer, Carcinoma, Endocrinology, Migraine, Neuralgia, Neurology, Oncology, Osteoarthritis, Pathology, Pharmaceuticals, Prostate Cancer, Puberty, Urology, Voltaren

Comments (0)

Download PDF Copy

Suggested Reading

Discovery of stem-like CD4 T cells offers new hope for cancer immunotherapy

Discovery of stem-like CD4 T cells offers new hope for cancer immunotherapy

Early RSV vaccination in pregnancy provides best protection for newborns

Early RSV vaccination in pregnancy provides best protection for newborns

MRI-guided SBRT reduces side effects in prostate cancer treatment

MRI-guided SBRT reduces side effects in prostate cancer treatment

Study links healthy diet to reduced progression of low-risk prostate cancer

Study links healthy diet to reduced progression of low-risk prostate cancer

Global leaders gather at the NFCR Summit to drive breakthroughs in cancer care

Global leaders gather at the NFCR Summit to drive breakthroughs in cancer care

Healthy lifestyle choices can offset genetic risk for brain diseases

Healthy lifestyle choices can offset genetic risk for brain diseases

Overtreatment of older men with prostate cancer raises concerns

Overtreatment of older men with prostate cancer raises concerns

New treatment combination improves outcomes for small cell bladder and prostate cancer patients

New treatment combination improves outcomes for small cell bladder and prostate cancer patients

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Obesity crisis in the U.S. expected to worsen by 2050